Ann: Viralytics to Present New CAVATAK Clinical Data at AACR, page-9

  1. 11,786 Posts.
    lightbulb Created with Sketch. 1720
    wow, yes what a difference a day makes.

    For the last few years the vla sp plods along or down and then out comes some trial results snippets and it goes up to a new level.

    Given two podium slots have been given and vla's constantly good trial result snippets I think we will hit a new high even before the news comes out.

    Of course it is not just that good results matter to us, but also to those looking to partner or do a take over. Maybe these results might just be the push needed for that to happen.

    ok, I shouldn't get too carried away yet, but it is nice to feel positivity after this years sp decline.

    Cheers
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.